Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s
2018 ◽
Vol 73
◽
pp. 372
1995 ◽
Vol 16
(11)
◽
pp. 627-632
◽
2012 ◽
Vol 54
(4)
◽
pp. 318-320
◽
2005 ◽
Vol 159
(6)
◽
pp. 596
2007 ◽
Vol 130
(1-2)
◽
pp. 285-291
◽
2014 ◽
Vol 8
(1)
◽
pp. 68
◽